Caffeic acid (3,4-dihydroxycinnamic acid), one of the moieties of chlorogenic acid, is a phenolic compound widely distributed in plant materials other than coffee, including vegetables and fruits.
Atopic dermatitis is a condition manifesting eczema, serous papules, scaling and crust and in severe cases, erosion of the affected skin. Itch, a sensation causing the urge to scratch, is the most significant outcome of atopic dermatitis, where insistent scratching further aggravates the skin symptoms of the disease. 5) In allergic conditions, histamine contained in skin mast cells, acts as one of the main mediators of itchness 6) ; and it has been proven that antiallergic drugs such as azelastine, oxatomide, terfenadine, epinastine and astemizole exert a relatively potent inhibitory effect on itch induced by compound 48/80 in animal models. 7) It is now accepted that drugs having an antioxidant effect have an antiallergic effect as well, and that superoxide generation plays an important role in mast cell activation. [8] [9] [10] The release of chemical mediators from tissue mast cells has been centrally implicated in a diversity of allergic and inflammatory disorders. Therefore, in the present study, the effect of caffeic acid on allergic symptoms such as skin scratching behavior and vascular hyperpermeability induced by compound 48/80 were investigated in ICR mice.
MATERIALS AND METHODS

Animals
Female ICR mice (6-10 weeks old) were obtained from Japan SLC, Inc. The animals were housed in an air-conditioned room maintained at 24Ϯ2°C with a relative humidity of 55Ϯ15%. They were given standard laboratory rodent chow (Oriental Yeast, Tokyo) and water ad libitum. All procedures involving animals were conducted in accordance with the Guidelines for Animal Experiments at Okayama University Advanced Science Research Center.
Drugs The reagents used in the experiments were obtained from the sources shown in parentheses: caffeic acid (Sigma, St. Louis, MO, U.S.A.), compound 48/80 (Sigma), tranilast (Kissei, Matsumoto, Japan). Caffeic acid and tranilast were suspended in 5% arabic gum, while compound 48/80 was dissolved in physiological saline.
Scratching Behavior Caffeic acid was administered to the animals orally, 1 h before starting the experiment. Later, 10 mg/0.02 ml compound 48/80 was intradermally injected into the rostral part of the shaved back of the mice. Immediately after the injection, the animals were put into an observation cage (11 cm in diameter, MicroAct, Neuroscience, Tokyo, Japan), which automatically and objectively detects and evaluates mouse-scratching behavior.
11) Scratching behavior was measured for 1 h.
Skin Histamine Content The mice were sacrificed under ether anesthesia and the rostral part of the back was excised, washed with ice-cold saline, and weighed. The samples were minced and then homogenized in 0.4 N perchloric acid using a Polytron (Kinematica, Lucerne, Switzerland) on ice. After centrifugation at 1500ϫg for 10 min at 4°C, the histamine content of the supernatant was measured using an autoanalyzer (Bran Luebbe, Osaka, Japan) and a fluorometric detector (Model U-2000, Hitachi, Tokyo, Japan) as described previously. 12) Compound 48/80 was administered intradermally into the rostral part of the back of the animals 1 h before starting the experiment.
Vascular Permeability of the Skin After intradermal injection of 0.5 mg/0.02 ml compound 48/80 into the rostral part of the back, 2% Evans blue solution was intravenously injected into each animal. The animals were sacrificed 30 min later, and the diameters of the 'bluing' area at the compound 48/80 injection site were measured. Caffeic acid was orally administered 1 h before the experiment.
Statistical Analysis All values are expressed as the meanϮstandard error of the mean (S.E.M.). Statistical evaluation of the results was performed by one-way analysis of variance (ANOVA) followed by Dunnett's test. A probability value less than 0.05 was considered statistically significant. Figure 1 shows the effect of a single administration of caffeic acid on compound 48/80-induced scratching behavior. Though caffeic acid showed no inhibitory effect at doses of 100 and 200 mg/kg, 500 mg/kg significantly inhibited compound 48/80-induced scratching behavior. Repeated administration of a lower dose of caffeic acid (200 mg/kg) for 3 weeks resulted in a gradual inhibition of the induced itch symptoms, which was significant after the second week of treatment. Tranilast at a dose of 300 mg/kg significantly diminished the number of scratches induced by compound 48/80 from the first day of treatment (Fig. 2) .
RESULTS
Compound 48/80-Induced Scratching Behavior
Changes in Dorsal Skin Histamine Content The results are shown in Table 1 . After the third week of treatment, following an intradermal injection of compound 48/80, the histamine remaining in the skin of the mice was determined. Consecutive administration of 200 mg/kg of caffeic acid and 300 mg/kg of tranilast significantly inhibited in vivo histamine release induced by compound 48/80. Vascular Permeability Changes in the Skin Caffeic acid at a dose of 200 mg/kg caused no significant inhibition of the increased skin vascular permeability induced by compound 48/80. However, at 500 mg/kg, it significantly inhibited induced vascular permeability (Table 2) . 13, 14) In this study, compound 48/80-induced scratching behavior in ICR mice was significantly inhibited by single and consecutive pretreatment with different doses of caffeic acid. Single administration of 500 mg/kg of caffeic acid significantly decreased the number of scratches induced by compound 48/80, however, taking into account that caffeic acid behaves as a stimulant of the central nervous system, 15) lower doses were tested to avoid undesirable effects. Caffeic acid is a metabolite of chlorogenic acid and the major source of chlorogenic acid is coffee. 16) Daily intake of caffeic acid in coffee drinkers is 0.1-1 g, while coffee abstainers ingest less than 100 mg per day of caffeic acid derived from fruits and vegetables. Therefore, we investigated the effects of consecutive administration of lower doses of caffeic acid, and found that 100 mg/kg slightly inhibited the elicited scratching behavior, although not significantly, after the third week of treatment. Furthermore, 200 mg/kg of caffeic acid administered daily for 3 weeks significantly inhibited compound 48/80-induced scratching behavior after the second week of treatment. Interestingly, the group of mice treated with 100 or 200 mg/kg of caffeic acid for 4 weeks showed an increase in scratching behavior during the fourth week (data not shown), an increase that although not equal in intensity to the control group, could be considered as a reverse reaction. On the other hand, tranilast, an antiallergic drug that inhibits the release of chemical mediators from mast cells, clearly blocked the itch response induced by compound 48/80 from the first day until the fourth week of treatment. Regarding coffee and allergy, there is controversy as to whether or not coffee ingestion triggers allergic symptoms. Uenishi et al. 17) have reported that exclusion of offending foods such as coffee, chocolate, cheese and yogurt from the daily diet, brings about a progressive improvement of allergic diseases in sensitive patients; while Pagano et al. 18) and Schwartz et al. 19) argued that coffee and caffeine reduce asthma symptoms. The present results appear to support the findings of Pagano et al. and Schwartz et al.
DISCUSSION
The specific mechanism of action of caffeic acid in inhibiting itch remains unclear. However, based on the evidence that caffeic acid significantly inhibited compound 48/80-induced histamine release from skin mast cells, we assumed that the inhibitory effects of scratching behavior may be attributable to the inhibition of mast cell degranulation. Recent reports provide evidence that the oxidative state and free radical generation play an important role in mast cell activation and degranulation. 20, 21) The antioxidant effect and histamine release inhibitory effect of caffeic acid have also been reported. 22, 23) Furthermore, natural products such as propolis, which contains caffeic acid has been reported to have antiallergic properties in vivo and in vitro. 24) On the other hand, Inagaki et al. 11) reported that compound 48/80 can induce scratching behavior in mice independent of mast cells based on the finding that mast cell-deficient mice also exhibited scratching behavior after injection of compound 48/80. From these findings, they proposed that scratching behavior induced by compound 48/80 occurred through a unique mechanism other than mast cell activation. Therefore, a mechanism other than mast cell degranulation is believed to be involved in the inhibition of compound 48/80-induced scratching behavior by caffeic acid.
Increased permeability in the microvasculature to macromolecules is one of the earliest events of acute inflammation and allergy, and mast cell mediators such as histamine and serotonin increase vascular permeability in various species. 25) When the effect of caffeic acid on vascular permeability induced by compound 48/80 was investigated, it was found that caffeic acid significantly inhibited leakage induced by the above mentioned compound. Thus, we assumed that this effect resulted from the inhibition of mast cell degranulation.
From the above findings, we can conclude that the inhibitory effects of caffeic acid on scratching behavior and vascular permeability may be due mainly to an inhibition of histamine release from mast cells, probably through prevention of superoxide anion generation.
